• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Cargill’s Stevia Sustainability Program Benchmarked by FSA

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Beyond Raw Launches Concept X Pre-Workout Line

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Verdure Sciences

    Applied Food Sciences, Inc.

    Atlantia Clinical Trials

    KLK OLEO

    Gencor
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Verdure Sciences

    Applied Food Sciences, Inc.

    Atlantia Clinical Trials

    KLK OLEO

    Gencor
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    The Cannabis Glow Up

    The notorious plant rises from its troubled history to provide new possibilities in cosmetics.

    The Cannabis Glow Up
    By Nicole Foss, MBA, MSN, RN, NeXtraction04.01.21
    Disclosure: Statements regarding phytocompounds, ingredients, indications and products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition. No content in this article, regardless of date, should be used as a substitute for direct medical advice from your doctor or other qualified clinician. 


    Cannabis* has a colorful history in the U.S. Once widely used as medicine in the 1800s, cannabis underwent a confusing (and racially fueled) re-branding to eventually become a primary target in the “War on Drugs.”

    (*Cannabis: Referring to formal naming of flowering annual plant genus within the Cannabaceae family. Can be further defined into species: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Cannabis includes both “hemp” and “high-THC” chemovars.)

    Initially, sometime around 1911, state-level legislation began prohibiting the cultivation of cannabis which culminated in federal-level prohibition with the passage of the “Marihuana Tax Act” of 1937. Then, as part of the 1960’s cultural awakening, there was a resurgence in cannabis interest and consumption. The movement was quickly abolished and pushed “underground” by the Controlled Substances Act of 1970, which classified “marijuana” or “cannabis” as a schedule 1 drug, the label reserved for “addictive compounds with no medicinal benefits.”

    Fast forward to 1996, to a starkly different opinion on cannabis with the establishment of the first “medical marijuana” measure (in California) allowing patients with “qualifying” (debilitating and chronic) medical conditions to access cannabis for medicinal relief. The relief is now largely understood to be effects from what is known technically as phytocompounds.

    A pivotal point in phytocompound research, manufacturing, product development, and availability took place in 2009, when Oregon established and implemented a low-THC cannabis (hemp) research program that shaped the framework for the Agricultural Act of 2014 (United States Congress, 2014).

    The 2014 Act allowed state-level hemp pilot programs to launch with institutions of higher education across the country. These programs emphasized cultivation techniques and field data gathering for a better understanding of hemp’s growing characteristics. It was not until 2018, when the most recent Agricultural Act passed, that low-THC cannabis, known as “hemp,” and its phytocannabinoid extract and phytocompounds would be considered legal for commerce and transport.

    Simultaneous to the expansion of hemp research program development and federal-level Agricultural Acts, Washington and Oregon established the first “Adult-Use Markets” (sometimes referred to as Recreational Markets). These new markets allowed for the sale and oversight of high-THC cannabis flower (formerly called marijuana) and consumer goods products. Fast forward to November 2020, 36 states and four territories have medical cannabis programs and 15 states and three territories have adult-use markets. As of January 2021, all but three states have either submitted or already established regulations allowing for hemp-based consumer goods products (including “smokable flower” and phytocannabinoid extracts). While a few states do not currently provide their residents legal access to cannabis, this does not prohibit a resident from having hemp-based products sent to their home for private use as per the 2018 Agricultural Improvement Act.

    In cosmetics, hemp seed oil** (or sometimes loosely called hemp oil) gained momentum as an early placeholder-ingredient and hero to the hemp industry at the close of the 20th century, (the hemp pioneer, Hempz, was founded in 1998), but phytocannabinoids, in the form of raw concentrate, were less widely adopted by the industry until approximately the arrival of the COVID-19 pandemic, which brought a sweeping change of heightened awareness to consumer health and wellness, spurring multiple market opportunities for hemp-derived products.

    (**Hemp seed oil refers to an omega-rich oil that is formed when hemp seeds are pressed. Hemp seed oil does not usually contain any appreciable amount of phytocannabinoids, though it is rich in other phytocompounds. The potential for reform has not gone unnoticed by regulatory departments and legal counsels for top cosmetic, food, and beverage brands. The changing tone from legal departments and executives now grants a new “green light” to chemists and formulators, who were previously stonewalled by the historical misperception of cannabis.)

    This has sparked the need for access to peer-reviewed literature (predominantly international), stability studies, and an upward battle for education by formulators eager to get up to speed on cannabinoids and cannabinoid ingredient uses in daily consumer products. The lack of cohesive education from the cannabis industry makes it all the more challenging to formulators who are faced with the importance of creating a balanced phytocompound profile within a formulation, as well as with the complex decision of delivery through “raw concentrate,” “nano-emulsion,” “oil-emulsion,” or the hundreds of other innovative technologies available for use in delivery of lipid-based molecules.

    New Look, New Possible Applications
    First discovered in 1992 by Lumír Hanuš and William Devane, the Endocannabinoid System (ECS) is thought to be comprised of two parts: receptors and compounds. At least two (if not 10 or more) receptors and numerous compounds, both endogenous and external, work together to form this complex hemostatic system.

    These pathways span from head to toe and are present on many types of cells. The complex regulatory system is involved with monitoring and regulating hormones, motor coordination, pain modulation, and, likely, neuroprotection. This chemical receptor network responds to the body’s naturally produced endocannabinoids, 2-AG and Anandamide, and tens if not more than 100 phytocannabinoids. (For purposes of this discussion, cannabinoids generally fall into three categories: endocannabinoids, phytocannabinoids, and synthetic cannabinoids).

    Plant-derived cannabinoids, phytocannabinoids, fall into three smaller sub-categories: acidic cannabinoids (plant-based); neutral cannabinoids (processed); and metabolic cannabinoids (created by chemical reactions rather than by the plant or excessive processing). Acidic cannabinoids are thought to be more bioavailable (as supported by recent animal studies—Hannon M, et al., 2020) due to their added chemical group (a carboxyl group). The acidic cannabinoids (e.g., CBDa, CBGa, THCa, CBCa) were previously thought to be inactive and possibly unstable and were thus abandoned for their neutral counterparts CBD, CBG, and Delta-9-THC. Neutral phytocannabinoids are thus widely researched and have an expanding list of clinical studies (both human and animal). New research is released nearly daily uncovering potential applications for the numerous chronic illnesses that lower the quality of life of billions of people in the world.

    Then there is the concept of the synergistic effects of phytocompounds such as terpenoids (terpenes), flavonoids, and cannabinoids working harmoniously within the ECS. Though still open to debate, the synergistic effects are sometimes referred to as the “entourage effect.” While the science behind terpenes is expanding, it is often used within the adult-use, high-THC cannabis industry to define a completely different classification system, whereby terpenes are used to categorize common indica, sativa, and hybrid-like “strains” (chemovars) as a way to sell/categorize cannabis flower in adult use markets.

    These categories reflect “induced effect” on the consumer. As such, terpenes are likely what cannabis connoisseurs claim are responsible for the sedating (anti-anxiolytic) or alerting effects of cannabis; aka indica and sativa, respectively. Ironically “indica” and “sativa” are also common terms when cannabis producers (cultivators) refer to plant growth structure, where indica-type (also called Afghani) plants are bushy, more squat, wide-growing patterned, and where sativa-like (tropical) plants grow tall and lengthy often with “skinnier” leaves. It is confusing—I know.

    Anecdotally, there is little to no doubt that the phytocompounds perform synergistically to induce effects on the body. The most elemental realization of this is the fact that a pure D9THC market (unregulated or regulated) does not exist. This is because Delta9THC alone is quite intolerable. Unlike the unpleasant nature of D9THC, cannabidiol (CBD) is well tolerated and, according to the World Health Organization, non-addicting and non-toxic (World Health Organization, 2018). The pathways and implications of this new compound class would seem to be endless in its impacts on the human body in disease and aging.

    The new overlap of wellness, beauty, self-care, and dawn of “inflamm-aging” has also fueled the expansion of cannabinoids being researched in R&D departments. Inflammation, according to cannabis research published worldwide, suggests several inflammatory pathways and receptors. The CB2 receptor, a main endocannabinoid receptor, is thought to play a key role in inflammation alongside phytocannabinoids. But the research does not stop there. The transient receptor potential channels (TRP), Adenosine receptors (A2A), and Cyclooxygenase (COX-2) pathways show great promise when it comes to a multitude of phytocannabinoid induced activation or inhibition as related to inflammation. These TRP channels are the same as those for capsaicin and turmeric.

    Anti-inflammatory cytokines may also play a role in the harmonious function of cannabinoids and terpenes. One study suggests that deficits in working memory and an age-related increase in pro-inflammatory cytokines were both reversed by beta-caryophyllene (BCP), a popular cannabis terpenoid (Lindsey, et al., 2019). Another terpene, Terpinolene, alongside NSAID administration in animals, was suggested to exert a synergistic anti-inflammatory and analgesic effect (Macedo, E., et al., 2016).

    Cannabinoids do not stop at reducing skin and muscle inflammation; they have also been shown to effect neuroinflammation. Cellular (in vitro) neuroinflammation models show promise for phytocompounds such as CBG in reduction of pro-inflammatory cytokines (i.e., IL-1β, TNF-α, IFN-γ) and potential effects against neuroinflammation and oxidative stress (Gugliandolo A., et al., 2018).

    Cannabigerolic acid (CBGa), discovered in 1965, is naturally abundant within the hemp plant and is referred to as the “stem cell” of cannabinoids. Many cannabinoids are naturally formed from CBGa through normal chemical synthesis of this compound into more commonly known counterparts such as CBDa (hemp varieties) and THCa (adult use varieties). Not surprisingly, an expanding amount of CBGa-specific hemp genetics are now being produced, allowing for another expansion of the cannabinoid market to include CBGa and CBG-based extracts.

    CBGa is thought to have a weak binding affinity to CB1 and CB2. Despite the possible inactivity at these traditional endocannabinoid receptors, the whole class of acidic cannabinoid [acids], including CBGa, have shown to be more potent PPARγ agonists than their decarboxylated analogues (Nadal X., et al., 2017). Many other chemical pathways such as the 5HT (serotonin) have shown promise when it comes to cannabinoids (Resstel, et al., 2009).
    Which cannabinoid profile, which terpenoid profile, which extraction method, and which delivery method are the questions cosmetic chemists are now asking themselves. The information exists for cosmetic chemists to answer these important, questions, and a plethora of anecdotal evidence is mounting behind fast-growing consumer demand which is further driving capital market spending and deployment of resources to research and the science behind the “glow up” of cannabis. 


    About the Author: Nicole Foss MBA, MSN, RN is vice president, NeXtraction Inc. She may be reached at info@nextraction.com.

    References
    1. Gugliandolo A, Pollastro F, Grassi G, Bramanti P, Mazzon E. In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid. Int J Mol Sci. 2018;19(7):1992. Published 2018 Jul 8. doi:10.3390/ijms19071992
    2. Hannon MB, Deabold KA, Talsma BN, Lyubimov A, Iqbal A, Zakharov A, Gamble LJ, Wakshlag JJ. Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles. J Vet Pharmacol Ther. 2020 Sep;43(5):508-511. doi: 10.1111/jvp.12896. Epub 2020 Jul 31. PMID: 32735381.
    3. Lindsey, L., Daphney, C., Oppong-Damoah, A., Uchakin, P., Abney, S., Uchakina, O., ... Murnane, K. (2019, June 04). The cannabinoid receptor 2 Agonist, β-caryophyllene, improves working memory and REDUCES circulating levels of specific proinflammatory cytokines in aged male mice. Retrieved February 23, 2021, from https://www.sciencedirect.com/science/article/abs/pii/S0166432819304516?via%3Dihub
    4. Macedo, E. M., Santos, W. C., Sousa, B. P., Neto, Lopes, E. M., Piauilino, C. A., Cunha, F. V., Sousa, D. P., Oliveira, F. A., & Almeida, F. R. (2016). Association of terpinolene and diclofenac presents antinociceptive and anti-inflammatory synergistic effects in a model of chronic inflammation. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 49(7), e5103. https://doi.org/10.1590/1414-431X20165103
    5. Nadal X, Del Río C, Casano S, et al. Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. Br J Pharmacol. 2017;174(23):4263-4276. doi:10.1111/bph.14019
    6. Resstel, L. B., Tavares, R. F., Lisboa, S. F., Joca, S. R., Corrêa, F. M., & Guimarães, F. S. (2009). 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioral and cardiovascular responses to acute restraint stress in rats. British journal of pharmacology, 156(1), 181–188. https://doi.org/10.1111/j.1476-5381.2008.00046.x
    7. World Health Organization- Expert Committee on Drug Dependence. (2018). CANNABIDIOL (CBD) Critical Review Report. Retrieved from: https://www.who.int/medicines/access/controlled-substances/CannabidiolCriticalReview.pdf
    8. United States Congress. https://www.congress.gov/bill/113th-congress/house-bill/2642
    Related Searches
    • Delivery & Dosage Technologies
    • Cosmeceuticals / Nutricosmetics
    • Healthcare Trends
    • Quality & Safety
    Related Knowledge Center
    • Cosmeceuticals / Nutricosmetics
    • Herbs & Botanicals
    • Delivery & Dosage Technologies

    Related Content

      Trending
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      • Coca-Cola To Phase Out Honest Tea Brand By Year’s End, Citing Supply Chain Challenges | Nutraceuticals World
      Breaking News
      • Thorne Relaunches Gut Health Test with Microbiome Wipe
      • Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      • GC Rieber Foundations Expand Philanthropic Efforts
      • Danone Celebrates 10th anniversary of Grant Program for Probiotics Research
      • Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      Nippon Paint Automotive Americas Appoints Robert Angart CEO and President
      Sustainability, Economy are Focus of BCF’s Annual Conference
      Demand for Rhino Shield Increases
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      New Breast Implant Surgery Guidelines to Enhance Patient Safety
      Rhythm Management Group Debuts RhythmSynergy Tech Platform
      FDA Approves Trial Completion for Virtual Incision's MIRA Platform
      Contract Pharma

      Latest Breaking News From Contract Pharma

      iECURE Enters Agreement with Center for Breakthrough Medicines
      CPDC Enters Clinical Manufacturing Deal with CellBion
      Olon to Build New R&D Center in Italy
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      K-Beauty Brand Siita Shares Plastic Decomposition Technology with the Beauty Industry
      Shellworks Raises $6.2 Million in Seed Funding
      Ulta Beauty Reports Record First Quarter 2022 Results
      Happi

      Latest Breaking News From Happi

      Honeywell Addresses Critical Issues Such as Sustainability, Workforce Training and Digitalization
      Monat Global Wins Four Stevie Awards in the 20th Annual American Business Awards
      Coty Expands Vegan Beauty Portfolio With New Rimmel Mascara
      Ink World

      Latest Breaking News From Ink World

      Orion to Finish Gas Black Expansion in Germany by Early 2023
      Richard Childress Racing Shows Off New Wraps for 2022 NASCAR Season
      ProAmpac Acquires Specialty Packaging, Inc.
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      UPM Raflatac accelerates label growth with acquisition
      Labelexpo Asia 2022 postponed
      Teklynx software helps Top Clean Injection validate labels
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Toetal Solutions Raises $1.02 Million in New Financing
      ManaMed's ManaSport Wearable Ultrasound Earns FDA Nod
      Ekso Bionics Names Jerome Wong as Interim CFO
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      SEMI Foundation Receives $1.5 Million Grant to Bolster Michigan’s Semiconductor Talent Pipeline
      onsemi Recognized by Fortune 500 for Its Transformation Journey
      LG Display Presents AI-Driven NFT Artwork on Transparent OLED

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login